Altfest L J & Co. Inc. Cuts Position in Aetna Inc. (NYSE:AET)

Altfest L J & Co. Inc. reduced its position in shares of Aetna Inc. (NYSE:AET) by 51.9% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 6,316 shares of the company’s stock after selling 6,816 shares during the period. Altfest L J & Co. Inc.’s holdings in Aetna were worth $959,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the stock. Liberty Capital Management Inc. raised its position in shares of Aetna by 206.9% in the second quarter. Liberty Capital Management Inc. now owns 933 shares of the company’s stock worth $144,000 after buying an additional 629 shares during the last quarter. FTB Advisors Inc. raised its position in shares of Aetna by 11.0% in the first quarter. FTB Advisors Inc. now owns 977 shares of the company’s stock worth $125,000 after buying an additional 97 shares during the last quarter. Signature Estate & Investment Advisors LLC bought a new position in shares of Aetna during the first quarter worth about $133,000. Horan Capital Management acquired a new position in shares of Aetna during the first quarter valued at $157,000. Finally, Guardian Life Insurance Co. of America raised its position in shares of Aetna by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock valued at $173,000 after buying an additional 9 shares in the last quarter. 91.73% of the stock is currently owned by institutional investors and hedge funds.

Aetna Inc. (AET) traded down 0.44% on Wednesday, hitting $155.58. 3,134,715 shares of the company were exchanged. The stock has a 50 day moving average of $153.22 and a 200 day moving average of $137.42. The company has a market capitalization of $51.61 billion, a price-to-earnings ratio of 47.45 and a beta of 0.54. Aetna Inc. has a 52 week low of $104.59 and a 52 week high of $157.55.

Aetna (NYSE:AET) last posted its quarterly earnings results on Thursday, August 3rd. The company reported $3.42 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.34 by $1.08. Aetna had a return on equity of 20.52% and a net margin of 2.52%. The business had revenue of $15.52 billion for the quarter, compared to the consensus estimate of $15.34 billion. During the same quarter in the prior year, the company earned $2.21 EPS. The business’s revenue was down 2.7% compared to the same quarter last year. Analysts predict that Aetna Inc. will post $9.43 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, July 28th. Investors of record on Thursday, July 13th were paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.29%. The ex-dividend date of this dividend was Tuesday, July 11th. Aetna’s dividend payout ratio (DPR) is currently 43.67%.

COPYRIGHT VIOLATION NOTICE: This report was first published by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this report on another site, it was illegally copied and reposted in violation of United States & international copyright & trademark legislation. The correct version of this report can be read at https://sportsperspectives.com/2017/08/09/altfest-l-j-co-inc-has-959000-stake-in-aetna-inc-nyseaet-updated.html.

Several equities research analysts have commented on the stock. UBS AG reaffirmed a “buy” rating and issued a $160.00 target price (up previously from $147.00) on shares of Aetna in a research note on Wednesday, May 17th. Cantor Fitzgerald reissued an “overweight” rating and set a $175.00 price objective (up previously from $150.00) on shares of Aetna in a research report on Wednesday. BidaskClub downgraded shares of Aetna from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Deutsche Bank AG raised their target price on shares of Aetna from $157.00 to $163.00 and gave the company a “hold” rating in a research report on Monday. Finally, Jefferies Group LLC reaffirmed a “hold” rating and issued a $163.00 target price (up previously from $157.00) on shares of Aetna in a research report on Friday, August 4th. Eight investment analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company. Aetna has an average rating of “Buy” and a consensus target price of $157.09.

In other Aetna news, EVP Margaret M. Mccarthy sold 27,028 shares of the stock in a transaction dated Wednesday, June 7th. The stock was sold at an average price of $149.23, for a total value of $4,033,388.44. Following the completion of the sale, the executive vice president now directly owns 33,563 shares in the company, valued at $5,008,606.49. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Chairman Mark T. Bertolini sold 103,547 shares of the stock in a transaction dated Wednesday, May 17th. The shares were sold at an average price of $140.79, for a total value of $14,578,382.13. Following the completion of the sale, the chairman now owns 659,888 shares of the company’s stock, valued at $92,905,631.52. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company’s stock.

About Aetna

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply